Crossref
Radioactive iodine (I-131) therapy for benign thyroid disease: a single-centre outcomes analysis
Endocrine Abstracts · 20.01.2026
DOI: 10.1530/endoabs.115.ep49 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine Abstracts, online erschienen am 20.01.2026. Verfasst von Robert E Lyons und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lyons, R. E., & Crowley, R. K. (2026). Radioactive iodine (I-131) therapy for benign thyroid disease: a single-centre outcomes analysis. Endocrine Abstracts. https://doi.org/10.1530/endoabs.115.ep49
Vancouver
Lyons RE, Crowley RK. Radioactive iodine (I-131) therapy for benign thyroid disease: a single-centre outcomes analysis. Endocrine Abstracts. 2026. doi:10.1530/endoabs.115.ep49
BibTeX
@article{Lyons2026,
author = {Lyons, Robert E and Crowley, Rachel K},
title = {Radioactive iodine (I-131) therapy for benign thyroid disease: a single-centre outcomes analysis},
journal = {Endocrine Abstracts},
year = {2026},
doi = {10.1530/endoabs.115.ep49}
}
EUVIMED